Loading...
The anti-fibrotic effect of GV1001 combined with gemcitabine on treatment of pancreatic ductal adenocarcinoma
GV1001 is a telomerase-based cancer vaccine made of a 16-mer telomerase reverse transcriptase (TERT) peptide, and human TERT, the rate-limiting subunit of the telomerase complex, is an attractive target for cancer vaccination. The aim of this study was to evaluate the effect of telomerase peptide va...
Na minha lista:
Udgivet i: | Oncotarget |
---|---|
Main Authors: | , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Impact Journals LLC
2016
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5342724/ https://ncbi.nlm.nih.gov/pubmed/27655706 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12057 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|